• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型的针对凝血因子IXa的酶联免疫吸附测定法可检测人血浆中的凝血因子IXa。

A novel factor IXa-specific enzyme-linked immunosorbent assay detects factor IXa in human plasma.

作者信息

Misenheimer Tina M, Lasarev Michael R, Kumfer Kraig T, Sheehan John P, Schwartz Bradford S

机构信息

Morgridge Institute for Research, Madison, Wisconsin, USA.

Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.

出版信息

Res Pract Thromb Haemost. 2024 Feb 5;8(1):102338. doi: 10.1016/j.rpth.2024.102338. eCollection 2024 Jan.

DOI:10.1016/j.rpth.2024.102338
PMID:38433974
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10907220/
Abstract

BACKGROUND

Factor (F)IXa activity has been detected in human plasma and may impact thrombotic risk. Current FIXa activity assays are complex and cumbersome.

OBJECTIVES

To develop a reproducible enzyme-linked immunosorbent assay (ELISA) using a novel monoclonal antibody that detects total FIXa in human plasma.

METHODS

A monoclonal antibody was raised against the new N-terminus exposed upon activation of FIX to FIXa by cleavage after R226. This antibody is specific for FIXa protease and does not recognize FIX zymogen or FIXα. The antibody was used to develop a FIXa-specific ELISA capable of quantifying total FIXa (free FIXa and FIXa-antithrombin complex) in human plasma. Total FIXa quantified using the ELISA was compared to that of FIXa-antithrombin quantified using modifications of a previously described ELISA.

RESULTS

The FIXa-specific ELISA was reproducible and quantified total FIXa in human plasma. Total FIXa levels correlated with FIXa-antithrombin levels.

CONCLUSION

A monoclonal antibody was developed that specifically detects human FIXa protease. A FIXa-specific ELISA using the new antibody is capable of reproducibly measuring total FIXa in human plasma (both free FIXa and FIXa-antithrombin). This assay should facilitate the evaluation of total FIXa levels in a variety of clinical circumstances.

摘要

背景

已在人血浆中检测到因子(F)IXa活性,其可能影响血栓形成风险。当前的FIXa活性检测方法复杂且繁琐。

目的

使用一种新型单克隆抗体开发一种可重复的酶联免疫吸附测定(ELISA),以检测人血浆中的总FIXa。

方法

制备针对FIX经R226位点裂解激活为FIXa后新暴露的N端的单克隆抗体。该抗体对FIXa蛋白酶具有特异性,不识别FIX酶原或FIXα。使用该抗体开发了一种FIXa特异性ELISA,能够定量人血浆中的总FIXa(游离FIXa和FIXa-抗凝血酶复合物)。将使用ELISA定量的总FIXa与使用先前描述的ELISA的改良方法定量的FIXa-抗凝血酶进行比较。

结果

FIXa特异性ELISA具有可重复性,可定量人血浆中的总FIXa。总FIXa水平与FIXa-抗凝血酶水平相关。

结论

开发了一种特异性检测人FIXa蛋白酶的单克隆抗体。使用该新抗体的FIXa特异性ELISA能够可重复地测量人血浆中的总FIXa(游离FIXa和FIXa-抗凝血酶)。该检测方法应有助于在各种临床情况下评估总FIXa水平。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d145/10907220/6ba2e9a4a89d/figs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d145/10907220/bb621cd71b7d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d145/10907220/36e2d976ed87/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d145/10907220/be7a8ae89d7e/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d145/10907220/15d0c34e60bb/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d145/10907220/6ba2e9a4a89d/figs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d145/10907220/bb621cd71b7d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d145/10907220/36e2d976ed87/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d145/10907220/be7a8ae89d7e/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d145/10907220/15d0c34e60bb/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d145/10907220/6ba2e9a4a89d/figs1.jpg

相似文献

1
A novel factor IXa-specific enzyme-linked immunosorbent assay detects factor IXa in human plasma.一种新型的针对凝血因子IXa的酶联免疫吸附测定法可检测人血浆中的凝血因子IXa。
Res Pract Thromb Haemost. 2024 Feb 5;8(1):102338. doi: 10.1016/j.rpth.2024.102338. eCollection 2024 Jan.
2
Selective disruption of heparin and antithrombin-mediated regulation of human factor IX.选择性破坏肝素和抗凝血酶介导的人凝血因子 IX 的调节。
J Thromb Haemost. 2015 Jun;13(6):1053-63. doi: 10.1111/jth.12960. Epub 2015 May 10.
3
Quantitation of seminal factor IX and factor IXa in fertile, nonfertile, and vasectomy subjects: a step closer toward identifying a functional clotting system in human semen.对可育、不育和输精管结扎男性受试者精液中凝血因子IX和活化凝血因子IX的定量分析:向确定人类精液中的功能性凝血系统迈进了一步。
J Androl. 2005 Jan-Feb;26(1):146-52.
4
Factor IXa variants resistant to plasma inhibitors enhance clot formation in vivo.因子 IXa 变异体对血浆抑制剂的耐药性增强了体内血栓的形成。
Blood. 2023 Apr 20;141(16):2022-2032. doi: 10.1182/blood.2022018083.
5
Low molecular weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: contribution of the serpin-independent mechanism.低分子量肝素通过直接靶向因子 IXa 抑制血浆凝血酶生成:丝氨酸蛋白酶抑制剂非依赖机制的贡献。
J Thromb Haemost. 2012 Oct;10(10):2086-98. doi: 10.1111/j.1538-7836.2012.04892.x.
6
Elevated Plasma Factor IXa Activity in Premenopausal Women on Hormonal Contraception.激素避孕的绝经前妇女血浆因子 IXa 活性升高。
Arterioscler Thromb Vasc Biol. 2018 Jan;38(1):266-274. doi: 10.1161/ATVBAHA.117.309919. Epub 2017 Nov 2.
7
Activated factor IX-antithrombin III complexes in human blood: quantification by an enzyme-linked differential antibody immunoassay and determination of the in vivo half-life.人血液中活化的因子IX-抗凝血酶III复合物:通过酶联差异抗体免疫测定法定量并测定体内半衰期。
J Lab Clin Med. 1991 Oct;118(4):317-25.
8
Emicizumab, A Bispecific Antibody to Factors IX/IXa and X/Xa, Does Not Interfere with Antithrombin or TFPI Activity In Vitro.依美珠单抗,一种针对因子IX/IXa和X/Xa的双特异性抗体,在体外不干扰抗凝血酶或组织因子途径抑制物的活性。
TH Open. 2018 Mar 16;2(1):e96-e103. doi: 10.1055/s-0038-1636538. eCollection 2018 Jan.
9
Probing activation-driven changes in coagulation factor IX by mass spectrometry.利用质谱技术探测凝血因子 IX 的激活驱动变化。
J Thromb Haemost. 2021 Jun;19(6):1447-1459. doi: 10.1111/jth.15288. Epub 2021 Apr 5.
10
Sodium-site in serine protease domain of human coagulation factor IXa: evidence from the crystal structure and molecular dynamics simulations study.人凝血因子 IXa 丝氨酸蛋白酶结构域中的钠离子结合位点:来自晶体结构和分子动力学模拟研究的证据。
J Thromb Haemost. 2019 Apr;17(4):574-584. doi: 10.1111/jth.14401. Epub 2019 Mar 6.

引用本文的文献

1
Skin Telocytes Could Fundament the Cellular Mechanisms of Wound Healing in Platelet-Rich Plasma Administration.皮肤 Telocytes 可能为富血小板血浆治疗中伤口愈合的细胞机制提供基础。
Cells. 2024 Aug 8;13(16):1321. doi: 10.3390/cells13161321.

本文引用的文献

1
Contact and intrinsic coagulation pathways are activated and associated with adverse clinical outcomes in COVID-19.接触和内在凝血途径在 COVID-19 中被激活,并与不良临床结局相关。
Blood Adv. 2022 Jun 14;6(11):3367-3377. doi: 10.1182/bloodadvances.2021006620.
2
Adequate Antithrombin III Level Predicts Survival in Severe COVID-19 Pneumonia.充足的抗凝血酶III水平可预测重症COVID-19肺炎患者的生存率。
Cureus. 2021 Oct 6;13(10):e18538. doi: 10.7759/cureus.18538. eCollection 2021 Oct.
3
Antithrombin III deficiency-induced coagulopathy in the context of COVID-19: a case series.
新型冠状病毒肺炎背景下抗凝血酶III缺乏所致凝血病:病例系列
Br J Haematol. 2021 Sep;194(6):1007-1009. doi: 10.1111/bjh.17575. Epub 2021 May 30.
4
Probing activation-driven changes in coagulation factor IX by mass spectrometry.利用质谱技术探测凝血因子 IX 的激活驱动变化。
J Thromb Haemost. 2021 Jun;19(6):1447-1459. doi: 10.1111/jth.15288. Epub 2021 Apr 5.
5
Association between antithrombin and mortality in patients with COVID-19. A possible link with obesity.COVID-19 患者的抗凝血酶与死亡率之间的关联。与肥胖之间可能存在联系。
Nutr Metab Cardiovasc Dis. 2020 Oct 30;30(11):1914-1919. doi: 10.1016/j.numecd.2020.07.040. Epub 2020 Jul 28.
6
Protease: Serpin complexes to assess contact system and intrinsic pathway activation.蛋白酶:丝氨酸蛋白酶抑制剂复合物用于评估接触系统和内源性途径激活。
Res Pract Thromb Haemost. 2020 Jun 25;4(5):789-798. doi: 10.1002/rth2.12389. eCollection 2020 Jul.
7
A candidate activation pathway for coagulation factor VII.凝血因子 VII 的候选激活途径。
Biochem J. 2019 Oct 15;476(19):2909-2926. doi: 10.1042/BCJ20190595.
8
Elevated Plasma Factor IXa Activity in Premenopausal Women on Hormonal Contraception.激素避孕的绝经前妇女血浆因子 IXa 活性升高。
Arterioscler Thromb Vasc Biol. 2018 Jan;38(1):266-274. doi: 10.1161/ATVBAHA.117.309919. Epub 2017 Nov 2.
9
Prethrombotic State in Young Very Low-Risk Patients With Atrial Fibrillation.年轻低风险房颤患者的血栓前状态
J Am Coll Cardiol. 2017 Apr 18;69(15):1990-1992. doi: 10.1016/j.jacc.2017.01.057.
10
Selective disruption of heparin and antithrombin-mediated regulation of human factor IX.选择性破坏肝素和抗凝血酶介导的人凝血因子 IX 的调节。
J Thromb Haemost. 2015 Jun;13(6):1053-63. doi: 10.1111/jth.12960. Epub 2015 May 10.